Iraq vs Saint Kitts and Nevis: Average non-HDL cholesterol levels
Iraq
3.5
in 2018
Saint Kitts and Nevis
3.5
in 2018
Iraq rank
52nd
Saint Kitts and Nevis rank
52nd
Average non-HDL cholesterol levels over time
- Iraq
- Saint Kitts and Nevis
How they compare
Iraq currently reports 3.5 against 3.5 in Saint Kitts and Nevis, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Iraq ahead.
Iraq ranks 52nd and Saint Kitts and Nevis ranks 52nd of 191 countries.
Iraq has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Iraq | Saint Kitts and Nevis | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.75 | 3.3 | 0.45 | Iraq |
| 1990s | 3.8 | 3.3 | 0.5 | Iraq |
| 2000s | 3.75 | 3.32 | 0.43 | Iraq |
| 2010s | 3.58 | 3.44 | 0.1333 | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Iraq or Saint Kitts and Nevis?
- Iraq, at 3.5 against 3.5 in Saint Kitts and Nevis as of 2018.
- What is the difference in average non-hdl cholesterol levels between Iraq and Saint Kitts and Nevis?
- 0, with Iraq ahead.
- How many years of comparable data are there for Iraq and Saint Kitts and Nevis?
- 39 years are reported by both, from 1980 to 2018.
- How do Iraq and Saint Kitts and Nevis rank globally for average non-hdl cholesterol levels?
- Iraq ranks 52nd and Saint Kitts and Nevis ranks 52nd of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.